The Happy Broadcast logo

General Anxiety Disorder is a condition that induces acute and exaggerated anxiety and worries about general life events without any specific trigger point.

Australian researchers are gearing up to kick off the world's first study into whether magic mushrooms can help treat general anxiety.
 Incannex Healthcare recently got approval from the Monash University Human Research Ethics Committee to launch their second-phase clinical trial.

They'll be using specialised therapy along with psilocybin to see if this winning combo can help reduce the effects of anxiety. Psilocybin is the active chemical in magic mushrooms that give recreational users that happy and trippy high.

Monash University Head of Clinical Psychedelic Research Paul Liknaitzky is leading the trial and said this is an incredible step forward in the fight against mental health disorders.

"For the first time ever, we're able to provide supported psilocybin sessions to research trial therapists to better equip them to accompany our clinical participants through profoundly unfamiliar terrain, potentially improving treatment outcomes,” Dr Liknaitzky said.

Source: News18